FDA NDC Directory · JSON-LD · Markdown

Nplate

NDC 55513-221 · HUMAN PRESCRIPTION DRUG · INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION

Generic nameromiplostim
Labeler / ManufacturerAmgen, Inc
Marketing categoryBiologic License Application · App BLA125268
Dosage form / routeINJECTION, POWDER, LYOPHILIZED, FOR SOLUTION · SUBCUTANEOUS
Active ingredientsROMIPLOSTIM (250 ug/.5mL)
Marketing started20080825
Package count2

External sources

Source: openFDA. Public-domain (CC0).